C7A.090
Malignant carcinoid tumor of the bronchus and lung
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant carcinoid tumors of the bronchus and lung are a rare form of neuroendocrine tumors originating in the lung's respiratory passages. These tumors are characterized by their potential to spread and grow aggressively if not diagnosed and treated promptly. Although they are classified as malignant, carcinoid tumors often grow slowly compared to other lung cancers, and their management varies based on the stage and location of the tumor.
Causes & Symptoms
Clinical Causes: Genetic factors that may predispose individuals to neuroendocrine tumors Exposure to certain carcinogens such as tobacco smoke Environmental factors including prolonged exposure to pollutants and toxins Pre-existing lung conditions that may influence tumor development Family history of neuroendocrine or lung tumors
Key Symptoms: Persistent cough that does not go away Coughing up blood or sputum containing blood Shortness of breath or wheezing Chest pain or discomfort Recurrent respiratory infections Hoarseness or difficulty speaking Unintended weight loss and fatigue
Diagnostic & Treatment
Diagnosis Path: Imaging Tests: Chest X-rays and computed tomography (CT) scans help visualize the tumor's size and location. Bronchoscopy: A procedure using a flexible tube inserted into the airways to examine the bronchus and obtain tissue samples. Biopsy: Tissue samples collected during bronchoscopy or other procedures are examined microscopically to confirm malignancy. Histopathological Analysis: Determines the tumor type and grade, assessing its potential for aggressive growth. Additional Tests: Positron emission tomography (PET) scans or magnetic resonance imaging (MRI) may be used to evaluate spread or metastasis. Laboratory Tests: Blood markers are not specific but can assist in overall health assessment.
Treatment Protocols: Surgical Removal: The primary treatment often involves resecting the tumor through procedures like lobectomy or sleeve resection to eliminate the malignant tissue. Radiation Therapy: May be used post-surgery or when surgery is not feasible, aiming to destroy remaining cancer cells. Chemotherapy: Although less common for carcinoid tumors, certain chemotherapeutic agents might be considered in advanced cases. Targeted Therapy: Emerging treatments targeting specific molecules involved in tumor growth are under investigation. Observation and Follow-up: Regular monitoring post-treatment is vital to detect any recurrence or progression.
Clinical Advice & FAQs
Billing Guidance
Is C7A.090 a billable ICD-10 code?
Yes, C7A.090 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C7A.090?
Clinical documentation must specify the nature of Malignant carcinoid tumor of the bronchus and lung and any associated comorbidities for accurate reporting.
Cite this Clinical Reference